European Pharmaceutical Journal impact factor, indexing, ranking (2024)


european

Aim and Scope

The European Pharmaceutical Journal is a research journal that publishes research related to Pharmacology, Toxicology and Pharmaceutics. This journal is published by the de Gruyter. The ISSN of this journal is 24536725. Based on the Scopus data, the SCImago Journal Rank (SJR) of european pharmaceutical journal is 0.117.

Also, please check the following important details about european pharmaceutical journal: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

European Pharmaceutical Journal Ranking

Journal Rank: 24472
SJR (SCImago Journal Rank): 0.117
Quartile: Q4
H-Index: 8

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.



Important Metrics

Journal Title: European Pharmaceutical Journal
Publisher: de Gruyter
ISSN: 24536725
Type: journal
Journal Scope: Pharmacology, Toxicology and Pharmaceutics
Country: Germany
H-Index: 8
SJR: 0.117
Quartile: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)

Indexing

The european pharmaceutical journal is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Quartile

The latest Quartile of european pharmaceutical journal is Q4.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

Based on the Official Journal Homepage, the european pharmaceutical journal does not charge any publication fee.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the european pharmaceutical journal publishes research articles in 21 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in European Pharmaceutical Journal?

If your research is related to Pharmacology, Toxicology and Pharmaceutics, then visit the official website of european pharmaceutical journal and send your manuscript.

Tips for publishing in European Pharmaceutical Journal:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • It is published by de Gruyter.
  • The journal is indexed in UGC CARE, Scopus, DOAJ.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 0.117.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 21 weeks.
  • Based on the Official Journal Homepage, the european pharmaceutical journal does not charge any publication fee.

Sources: https://sciendo.com/journal/AFPUC







SIMILIAR JOURNALS


ALCOHOL

ISSN: 0741-8329
Publisher: ELSEVIER SCIENCE INC

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY

ISSN: 0362-1642
Publisher: ANNUAL REVIEWS

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

ISSN: 1742-7835
Publisher: WILEY

BMC PHARMACOLOGY & TOXICOLOGY

ISSN:
Publisher: BMC

CHEMICO-BIOLOGICAL INTERACTIONS

ISSN: 0009-2797
Publisher: ELSEVIER IRELAND LTD

DRUG AND CHEMICAL TOXICOLOGY

ISSN: 0148-0545
Publisher: TAYLOR & FRANCIS LTD

DRUGS

ISSN: 0012-6667
Publisher: ADIS INT LTD

DRUG SAFETY

ISSN: 0114-5916
Publisher: ADIS INT LTD

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

ISSN: 1382-6689
Publisher: ELSEVIER

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

ISSN: 1742-5255
Publisher: TAYLOR & FRANCIS LTD

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.